NEW YORK--(BUSINESS WIRE)--Covidien (NYSE:COV), a leading global provider of healthcare products, today announced that results from a prospective, multicenter study using the VNUS ClosureFAST™ catheter, demonstrated clinical efficacy and improvement in quality of life for patients. The ClosureFAST catheter is an endovenous radiofrequency (RF) ablation catheter designed to heat and close diseased veins, the major underlying cause of varicose veins.
